MS Drug, Tysabri, Continues to Cause Disastrous Side Effects & a Natural Non-Toxic Treatment
In the latest blow to the controversial multiple sclerosis drug Tysabri, the U.S. Food and Drug Administration has ordered a new label be put on the drug, warning that the risk of developing progressive multifocal leukoencephalopathy (PML), a rare but deadly brain infection, increases as more Tysabri infusions are received. Natalizumab (Tysabri) first received FDA approval in November 2004, only to be pulled from the market three months later after several patients in clinical trials developed PML.
In June 2006, the FDA allowed the drug back on the market, but with strict conditions. According to those revised guidelines, Tysabri can only be administered by approved doctors at sites that register and comply with a patient-safety program. The new action was based on reports of 31 confirmed cases of PML as of January 21, 2010.
Business Week February 5, 2010
Multiple sclerosis is a chronic, degenerative disease of the nerves in your brain and spinal column, caused through a demyelization process.
If you choose the conventional approach to healing, you should know that neurologists (the specialists who typically monitor these types of diseases) routinely prescribe a variety of very toxic and dangerous medications to their MS patients -- medications that in no way, shape or form address the underlying cause of the disease. Further, as in the case of Tysabri, the treatment could actually kill you.
Why is Tysabri Even Back on the Market?
Tysabri first hit the market in November 2004 under an accelerated program the FDA reserves for drugs it believes will have “extraordinary benefits” to patients. It was touted as the “miracle” drug for MS because the results from the first year of clinical trials showed that MS patients who took Tysabri for one year had a 66 percent reduction in relapses compared to those who took a placebo.
But this wonder drug turned out to have a very dark side. Tysabri is a type of drug known as a monoclonal antibody, meaning it is derived from a mouse antibody that has been genetically engineered to mirror a human antibody (antibodies are proteins that help your body fight infection).
It is given every four weeks by infusion directly into a vein, where the antibodies bind to immune system cells, inhibiting them from crossing over from the bloodstream to the brain.
Tysabri blocks this movement by attaching to alpha 4-integrin, a protein on the surface of immune T cells that normally enables them to pass through the blood-brain barrier. However, if destructive immune system cells break free of the bloodstream, they can reach your brain, gastrointestinal tract and joints and cause severe damage.
Trading MS for a Deadly Brain Infection
Three months after Tysabri first hit the market it was pulled because one in 1,000 people who took it during clinical trials developed progressive multifocal leukoencephalopathy (PML), a rare brain infection that results in death or severe disablement. Dr. Lawrence Steinman, a Stanford University professor and an MS specialist who has developed MS drugs himself, said he repeatedly warned the FDA of the potential for serious immune-system side effects with Tysabri and drugs like it prior to approval.
Nonetheless, in June 2006 the FDA voted that Tysabri be returned to the market. Now, nearly four years later, the FDA has added a new label warning to Tysabri, warning health care professionals and patients that the risks of PML increase as more infusions are received. The drug may also cause liver damage.
If you have MS, it is my strong recommendation to not accept these drugs, or the other commonly prescribed MS drugs like prednisone or interferon, as they can seriously harm your health.
Is there a non-toxic natural method of treatment for MS? (from Lita Lee, Ph.D.)
Yes! You can find it on Dr. Ray Peat’s website, http://www.raypeat.com/
Title of his article: Multiple sclerosis, protein, fats, and progesterone
Link to this article: http://raypeat.com/articles/articles/ms.shtml